BPIQ Blog

Mar 28, 20192 min read

SUPN Reports Mixed Results in ADHD

SUPN reported mixed positive results today for its final phase 3 trial for SPN-812 in attention deficit hyperactivity disorder (ADHD).*...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity

bottom of page